StockWatch
·
Pharmaceuticals
Board Meeting27 Oct 2026, 02:24 pm

Hester Biosciences Board Meeting on Nov 5 to Review Financial Results

AI Summary

Hester Biosciences Ltd has announced that its Board of Directors will convene on November 5, 2026. The primary agenda item for this meeting is the consideration and approval of the unaudited standalone and consolidated financial results for the quarter and six-month period ending September 30, 2026. This announcement is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Highlights

  • Board meeting scheduled for November 5, 2026.
  • Agenda includes review of Q2 FY27 financial results.
  • Both standalone and consolidated results will be considered.
  • Disclosure made as per SEBI Listing Regulations.